Insider Trading Alert - CBPO, AB And AAOI Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer.

Yesterday, June 17, 2015, 81 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $59.52 to $530,454,750.00.

Highlighted Stocks Traded by Insiders:

China Biologic Products (CBPO) - FREE Research Report

WP X Biologics LLC, who is Director at China Biologic Products, sold 5.3 million shares at $100.28 on June 17, 2015. Following this transaction, the Director owned 8.3 million shares meaning that the stake was reduced by 38.8% with the 5.3 million-share transaction.

The shares most recently traded at $119.86, up $19.58, or 16.34% since the insider transaction. Historical insider transactions for China Biologic Products go as follows:

  • 4-Week # shares sold: 9,580
  • 12-Week # shares sold: 9,580
  • 24-Week # shares sold: 9,580

The average volume for China Biologic Products has been 150,900 shares per day over the past 30 days. China Biologic Products has a market cap of $2.8 billion and is part of the health care sector and drugs industry. Shares are up 69.73% year-to-date as of the close of trading on Wednesday.

China Biologic Products, Inc. engages in the research, development, manufacture, and sale of human plasma-based biopharmaceutical products to hospitals and inoculation centers in the People's Republic of China. The company has a P/E ratio of 39.5. Currently, there are 2 analysts who rate China Biologic Products a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on CBPO - FREE

TheStreet Quant Ratings rates China Biologic Products as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, solid stock price performance and impressive record of earnings per share growth. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. Get the full China Biologic Products Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

AllianceBernstein Holding L.P (AB) - FREE Research Report

Farrell Edward J, who is SVP and Controller at AllianceBernstein Holding L.P, sold 5,000 shares at $31.10 on June 17, 2015. Following this transaction, the SVP and Controller owned 30,165 shares meaning that the stake was reduced by 14.22% with the 5,000-share transaction.

The shares most recently traded at $30.73, down $0.37, or 1.2% since the insider transaction.

The average volume for AllianceBernstein Holding L.P has been 241,500 shares per day over the past 30 days. AllianceBernstein Holding L.P has a market cap of $3.1 billion and is part of the financial sector and financial services industry. Shares are up 20.02% year-to-date as of the close of trading on Wednesday.

AllianceBernstein Holding L.P. provides investment management and related services in the United States and internationally. The stock currently has a dividend yield of 5.81%. The company has a P/E ratio of 14.3. Currently, there are 2 analysts who rate AllianceBernstein Holding L.P a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on AB - FREE

TheStreet Quant Ratings rates AllianceBernstein Holding L.P as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, solid stock price performance, growth in earnings per share, compelling growth in net income and expanding profit margins. We feel its strengths outweigh the fact that the company shows weak operating cash flow. Get the full AllianceBernstein Holding L.P Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Applied Optoelectronics (AAOI) - FREE Research Report

Li Chung-Yao (Ford), who is Shareholder at Applied Optoelectronics, sold 12,750 shares at $18.74 on June 17, 2015. Following this transaction, the Shareholder owned 0 shares meaning that the stake was reduced by 100% with the 12,750-share transaction.

The shares most recently traded at $18.99, up $0.25, or 1.33% since the insider transaction. Historical insider transactions for Applied Optoelectronics go as follows:

  • 4-Week # shares sold: 3,000
  • 12-Week # shares sold: 14,787
  • 24-Week # shares sold: 14,787

The average volume for Applied Optoelectronics has been 258,800 shares per day over the past 30 days. Applied Optoelectronics has a market cap of $281.8 million and is part of the technology sector and electronics industry. Shares are up 68.09% year-to-date as of the close of trading on Wednesday.

Applied Optoelectronics, Inc. designs and manufactures optical communications products for Internet data center, cable television (CATV), and fiber-to-the-home markets. The company has a P/E ratio of 85.7. Currently, there are 6 analysts who rate Applied Optoelectronics a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on AAOI - FREE

TheStreet Quant Ratings rates Applied Optoelectronics as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, expanding profit margins and notable return on equity. However, as a counter to these strengths, we also find weaknesses including a generally disappointing performance in the stock itself, unimpressive growth in net income and weak operating cash flow. Get the full Applied Optoelectronics Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

More from Markets

Disney Must Launch Sky Counter Bid; Symantec Garners Activist Attention -- ICYMI

Disney Must Launch Sky Counter Bid; Symantec Garners Activist Attention -- ICYMI

Is Nvidia Still Tech's Most Explosive Stock? A Bull and Bear Debate

Is Nvidia Still Tech's Most Explosive Stock? A Bull and Bear Debate

Nvidia Shares Fall After Beating Earnings but Issuing Light Guidance

Nvidia Shares Fall After Beating Earnings but Issuing Light Guidance

Rewind: Jim Cramer on the Stock Market Rebound, Walmart, Amazon and JCPenney

Rewind: Jim Cramer on the Stock Market Rebound, Walmart, Amazon and JCPenney

Teva Notches Win With FDA Approval of Generic EpiPen

Teva Notches Win With FDA Approval of Generic EpiPen